A newly approved histamine H3 receptor antagonist/inverse agonist offers a non-scheduled treatment option for excessive daytime sleepiness in Japanese patients.

Although the 2027 Current Procedural Terminology (CPT) Professional Manual is not yet available, sleep medicine professionals can start preparing now for upcoming changes to unattended sleep testing codes. The September...

On Sept. 21, 2026, the Centers for Medicare & Medicaid Services (CMS) announced that 2025 participants in the Merit-based Incentive Payment System (MIPS) can now view their performance feedback, including final score...

A new publication distills insights from over 100 expert interviews to explore clinical practice, technology, and patient advocacy shifts in the sleep field.

The circadian regulator shifted sleep onset significantly earlier in adults, paving the way for a potential FDA submission for a new indication.

At the AASM, you are part of a community that shares your passion, supports your growth, and advances the future of sleep medicine. Your people are here. Your strength is here. And your AASM is here to help you stay conn...

Outsourcing aspects of HST to a vendor can free up in-house staff time. This guide compares HST services programs on payment, devices used, scoring and interpretation options, turnaround time, patient education, patient...

A locally acting nighttime nasal spray designed to restore natural neuromuscular control of the upper airway during sleep showed safety and tolerability in healthy volunteers, paving the way for further trials.

The investment will add 20,000 sq ft to the custom dental manufacturer's headquarters, supporting international growth and increased production of oral appliances for obstructive sleep apnea.

A recent survey reveals that just 5% of parents with young children get recommended sleep, with over a quarter showing signs of undiagnosed sleep apnea, highlighting an urgent need for clinical intervention and broadened...